Gut microbiota dysbiosis in polycystic ovary syndrome: Mechanisms of progression and clinical applications

Front Cell Infect Microbiol. 2023 Feb 24:13:1142041. doi: 10.3389/fcimb.2023.1142041. eCollection 2023.

Abstract

Polycystic ovary syndrome (PCOS) is the most common endocrine diseases in women of childbearing age that leads to menstrual disorders and infertility. The pathogenesis of PCOS is complex and has not yet been fully clarified. Gut microbiota is associated with disorders of lipid, glucose, and steroid hormone metabolish. A large body of studies demonstrated that gut microbiota could regulate the synthesis and secretion of insulin, and affect androgen metabolism and follicle development, providing us a novel idea for unravelling the pathogenesis of PCOS. The relationship between gut microbiota and the pathogenesis of PCOS is particularly important. This study reviewed recent research advances in the roles of gut microbiota in the occurrence and development of PCOS. It is expected to provide a new direction for the treatment of PCOS based on gut microbiota.

Keywords: Polycystic ovary syndrome; gut microbiota; infertility; insulin; women.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Dysbiosis / complications
  • Female
  • Gastrointestinal Microbiome* / physiology
  • Humans
  • Insulin
  • Insulin Resistance*
  • Polycystic Ovary Syndrome* / drug therapy

Substances

  • Insulin

Grants and funding

This work was supported by a grant from Natural Science Foundation of Science and Technology Department of Jilin Province (YDZJ202201ZYTS033).